Outcomes Network Graph
Outcomes Flow Chart
Conditions Resulting from Methotrexate
User-reported conditions resulting from Methotrexate based on their intuition.
| Resulting Condition | Agree |
|---|---|
| Fibromyalgia | 1% |
Treatment Effectiveness
User reported effectiveness ratings Methotrexate for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Chronic Cerebrospinal Venous Insufficiency (CCSVI) | 0% | 100% | 0% | 0% | 0% | 1 |
| Knee Pain | 0% | 0% | 0% | 67% | 33% | 3 |
| Palindromic Rheumatism | 22% | 19% | 11% | 41% | 7% | 27 |
| Psoriasis | 16% | 44% | 8% | 28% | 4% | 25 |
Side Effects
User-reported side effects of Methotrexate
| Side Effect | Percent of Reports Methotrexate |
|---|---|
| Decreased Appetite | 22% |
| Dizziness | 30% |
| Drowsiness | 33% |
| Hair Loss | 38% |
| Rash Everywhere | 11% |
| Reddened Eyes | 9% |
| Swollen, Tender Gums | 20% |
| Headache | 31% |
Outcomes
Below is the degree of change seen after Methotrexate is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Daily Distribution
Average by Year
Average by Month
Average by Day of Week
Outcomes Label
Methotrexate Info
| Property | Value |
|---|---|
| Variable Name | Methotrexate |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-09-17 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Kurtosis | 21.345547911788 |
| Mean | 5.15873 count |
| Median | 0 count |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 2 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 2 |
| Public | true |
| Onset Delay | 30 minutes |
| Standard Deviation | 2.1133306009514 |
| Unit | Count |
| User Variables | 2 |
| UPC | 811855818678 |
| Variable Category | Treatments |
| Variable ID | 94368 |
| Variance | 4.5858934971838 |